Recursion Pharmaceuticals, Inc. (RXRX) ownership: Top institutional holder: VANGUARD GROUP INC ($193.00M). Insider activity: Net Seller (0 buys, 20 sells). SEC EDGAR first-party data.
| Holder | Shares | Market Value | Reported |
|---|---|---|---|
| VANGUARD GROUP INC | 47187759.00 | $193.00M | 2025-12-31 |
| BlackRock, Inc. | 43192306.00 | $132.60M | 2026-03-31 |
| ARK Investment Management LLC | 40212769.00 | $123.45M | 2026-03-31 |
| STATE STREET CORP | 28490638.00 | $87.47M | 2026-03-31 |
| BAILLIE GIFFORD & CO | 23675407.00 | $72.68M | 2026-03-31 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 22759100.00 | $69.87M | 2026-03-31 |
| VANGUARD CAPITAL MANAGEMENT LLC | 22244387.00 | $68.29M | 2026-03-31 |
| SOFTBANK GROUP CORP. | 13636515.00 | $41.86M | 2026-03-31 |
| Insider | Transaction | Value | Date |
|---|---|---|---|
| Sell | null | 2026-08-17 | |
| Sell | null | 2026-08-17 | |
| Sell | null | 2026-08-17 | |
| Sell | null | 2026-08-04 | |
| Sell | null | 2026-07-07 | |
| Sell | null | 2026-07-01 | |
| Sell | null | 2026-07-01 | |
| Sell | null | 2026-06-17 |
Back to RXRX overview · RXRX earnings · All congressional trades
Institutional data from SEC Form 13F. Insider data from SEC Form 4. Congressional data from STOCK Act disclosures. Not personalized investment advice.